Literature DB >> 34350508

Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer's disease: flavonoids and phenols.

Meng Zhang1, Guanhua Hu1, Nan Shao1, Yunpeng Qin1, Qian Chen1, Yan Wang1, Peng Zhou2,3,4, Biao Cai5,6,7.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease characterized by amyloid plaques and tangles that have become the fifth leading cause of death worldwide. Previous studies have found that thioredoxin interacting protein (TXNIP) expression was increased during the development of AD neurons. TXNIP separates from the TXNIP-thioredoxin complex, and the TXNIP-NLRP3 complex assembles ASC and pro-caspase-1 to form the NLRP3 inflammasome, which triggers AD inflammation and apoptosis. CB-dock was used to explore whether 21 natural flavonoids and phenols target TXNIP based on references. Docking results showed that rutin, puerarin, baicalin, luteolin and quercetin are the most potent TXNIP inhibitors, and among them, rutin as the most effective flavonoid. And rosmarinic acid is the most potent TXNIP inhibitor of phenols. These phytochemicals could be helpful to find the lead compounds in designing and developing novel agents for Alzheimer's disease.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Alzheimer’s disease; Flavonoids; Molecular docking; Phenols; Thioredoxin-interacting protein

Mesh:

Substances:

Year:  2021        PMID: 34350508     DOI: 10.1007/s10787-021-00861-4

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  146 in total

1.  Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease.

Authors:  Larry Baum; Christopher Wai Kei Lam; Stanley Kwok-Kuen Cheung; Timothy Kwok; Victor Lui; Joshua Tsoh; Linda Lam; Vivian Leung; Elsie Hui; Chelsia Ng; Jean Woo; Helen Fung Kum Chiu; William B Goggins; Benny Chung-Ying Zee; King Fai Cheng; Carmen Yuet Shim Fong; Adrian Wong; Hazel Mok; Moses Sing Sum Chow; Ping Chuen Ho; Siu Po Ip; Chung Shun Ho; Xiong Wen Yu; Caroline Yau Lin Lai; Ming-Houng Chan; Samuel Szeto; Iris Hiu Shuen Chan; Vincent Mok
Journal:  J Clin Psychopharmacol       Date:  2008-02       Impact factor: 3.153

2.  Resveratrol Decreases TXNIP mRNA and Protein Nuclear Expressions With an Arterial Function Improvement in Old Mice.

Authors:  Tatiana Bedarida; Stephanie Baron; Françoise Vibert; Audrey Ayer; Daniel Henrion; Elizabeth Thioulouse; Carmen Marchiol; Jean-Louis Beaudeux; Charles-Henry Cottart; Valerie Nivet-Antoine
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-06-03       Impact factor: 6.053

Review 3.  Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?

Authors:  Justine M Abais; Min Xia; Yang Zhang; Krishna M Boini; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2015-01-19       Impact factor: 8.401

Review 4.  Application of quercetin in neurological disorders: from nutrition to nanomedicine.

Authors:  Elnaz Amanzadeh; Abolghasem Esmaeili; Soheila Rahgozar; Maryam Nourbakhshnia
Journal:  Rev Neurosci       Date:  2019-07-26       Impact factor: 4.353

5.  Isorhamnetin and hyperoside derived from water dropwort inhibits inflammasome activation.

Authors:  Huijeong Ahn; Geun-Shik Lee
Journal:  Phytomedicine       Date:  2016-11-23       Impact factor: 5.340

Review 6.  Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases.

Authors:  Jinrong Bai; Yunsen Zhang; Ce Tang; Ya Hou; Xiaopeng Ai; Xiaorui Chen; Yi Zhang; Xiaobo Wang; Xianli Meng
Journal:  Biomed Pharmacother       Date:  2020-11-16       Impact factor: 6.529

Review 7.  Rosmarinic acid: modes of action, medicinal values and health benefits.

Authors:  Mahmoud Alagawany; Mohamed Ezzat Abd El-Hack; Mayada Ragab Farag; Marappan Gopi; Kumaragurubaran Karthik; Yashpal Singh Malik; Kuldeep Dhama
Journal:  Anim Health Res Rev       Date:  2017-11-07       Impact factor: 2.615

8.  Naringenin Upregulates AMPK-Mediated Autophagy to Rescue Neuronal Cells From β-Amyloid (1-42) Evoked Neurotoxicity.

Authors:  Aitizaz Ul Ahsan; Vijay Lakshmi Sharma; Abubakar Wani; Mani Chopra
Journal:  Mol Neurobiol       Date:  2020-06-16       Impact factor: 5.682

9.  Rutin Isolated from Chrozophora tinctoria Enhances Bone Cell Proliferation and Ossification Markers.

Authors:  Ashraf B Abdel-Naim; Abdullah A Alghamdi; Mardi M Algandaby; Fahad A Al-Abbasi; Ahmed M Al-Abd; Basma G Eid; Hossam M Abdallah; Ali M El-Halawany
Journal:  Oxid Med Cell Longev       Date:  2018-02-13       Impact factor: 6.543

10.  Mangiferin and Morin Attenuate Oxidative Stress, Mitochondrial Dysfunction, and Neurocytotoxicity, Induced by Amyloid Beta Oligomers.

Authors:  Elena Alberdi; María Victoria Sánchez-Gómez; Asier Ruiz; Fabio Cavaliere; Carolina Ortiz-Sanz; Tania Quintela-López; Estibaliz Capetillo-Zarate; Santiago Solé-Domènech; Carlos Matute
Journal:  Oxid Med Cell Longev       Date:  2018-06-14       Impact factor: 6.543

View more
  4 in total

1.  N-Lobe of TXNIP Is Critical in the Allosteric Regulation of NLRP3 via TXNIP Binding.

Authors:  Fengyu Cheng; Nan Wang
Journal:  Front Aging Neurosci       Date:  2022-06-02       Impact factor: 5.702

Review 2.  α-Arrestins and Their Functions: From Yeast to Human Health.

Authors:  Kacper Zbieralski; Donata Wawrzycka
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

3.  Interleukin-35 attenuates blood-brain barrier dysfunction caused by cerebral ischemia-reperfusion injury through inhibiting brain endothelial cell injury.

Authors:  Lei Qian; Ming Li; Xin Lin; Hongwei Teng; Lulu Yu; Maorong Jiang
Journal:  Ann Transl Med       Date:  2022-07

Review 4.  Exosomes Regulate NLRP3 Inflammasome in Diseases.

Authors:  Zhangwang Li; Xinyue Chen; Junjie Tao; Ao Shi; Jing Zhang; Peng Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.